Our research provided a novel mechanism for the stemness of hepatic cancer cells conferred by HBx and raised BNIP3L as a possible therapeutic target for liver cancer stem cells (LCSCs)-associated HCC. The gene discussed is BNIP3L; the disease is hepatocellular carcinoma.